Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs: 1 blog
twitter: 10 X users

patent: 4 patents

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 58 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

GENETICALLY ENGINEERED DOUBLE NEGATIVE T CELLS AS AN ADOPTIVE CELLULAR THERAPY

Application EP-4069831-A4

European Patent Office

METHOD FOR EFFICIENTLY AND STABLY TRANSDUCING ANTIGEN CHIMERIC RECEPTOR DOUBLE-NEGATIVE T…

Application WO-2023078425-A1

World Intellectual Property Organisation (WIPO)

Genetically engineered double negative T cells as adoptive cell therapy

Application CN-114929865-A

China

GENETICALLY ENGINEERED DOUBLE NEGATIVE T CELLS AS AN ADOPTIVE CELLULAR THERAPY

Application WO-2021108926-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.